Comparative effectiveness of targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Comparative effectiveness of targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis

Published:2018-07 Issue:1 Volume:79 Page:135-144.e7
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Loos Anne M.,Liu Shanshan,Segel Celia,Ollendorf Daniel A.,Pearson Steven D.,Linder Jeffrey A.

Publisher

Elsevier BV

Subject

Dermatology

Reference42 articles.

1. Global Report on Psoriasis,2016

2. Comparative efficacy of biological treatments for moderate-to-severe psoriasis: a network meta-analysis adjusting for cross-trial differences in reference arm response;Signorovitch;Br J Dermatol.,2015

3. Comparison of ustekinumab with other biological agents for the treatment of moderate to severe plaque psoriasis: A Bayesian Network meta-analysis;Lin;Arch Dermatol.,2012

4. Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials;Reich;Br J Dermatol.,2012

5. The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis;Schmitt;Dermatology,2005

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Interleukin-17 Inhibitors on Major Adverse Cardiovascular Events in Psoriasis or Psoriatic Arthritis Patients Naive to Biologic Agents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Cureus;2024-05-24

2. Association between the neutrophil-to-lymphocyte ratio and psoriasis: a cross-sectional study of the National Health and Nutrition Examination Survey 2011–2014;BMJ Open;2023-12

3. Ixekizumab for the treatment of moderate-to-severe plaque psoriasis: the first septennium;Immunotherapy;2023-10

4. Retrospective pharmacogenetic study of psoriasis highlights the role of KLK7 in tumour necrosis factor signalling;British Journal of Dermatology;2023-09-06

5. Estimate of the cost per responder for treatment with biological therapies of moderate-to-severe plaque psoriasis in Colombia for first-year and maintenance periods;Expert Review of Pharmacoeconomics & Outcomes Research;2023-03-29